Health ❯ Healthcare

Cost-Effectiveness

Healthcare Economics Health Economics NHS Drug Pricing NHS Funding Medical Research NICE Guidelines Patient Outcomes Clinical Implementation Healthcare Policy Medical Interventions Diagnostic Tools Treatment Options Affordable Medications NHS Services Quality-Adjusted Life-Year NHS Evaluation Medical Economics Health Policy Vaccine Pricing NICE Resource Allocation Healthcare Savings Drug Evaluation Treatment Regimens Healthcare Technology Surgical Practices Economic Evaluation Healthcare Systems NICE Recommendations

UK Clears Aficamten (MYQORZO) for Symptomatic Obstructive Hypertrophic Cardiomyopathy

NICE recommendation and a confidential NHS discount mean about 6,600 eligible adults could start the once‑daily pill within weeks.

HPV Vaccination Could Allow Much Rarer Cervical Screening, Norway Study Finds

Apple Watch Screening Quadruples AFib Detection in High-Risk Seniors, EQUAL RCT Finds

Large Swedish Study Finds ARBs Sustain the Best Long-Term Adherence in Hypertension

TCT 2025: Stent‑Sparing Balloons Match DES at One Year as Lower‑Cost Alternatives Rival IVL

Targeting Systolic Blood Pressure Below 120 mm Hg Is Cost-Effective, Simulation Finds

Six-Month Eculizumab Withdrawal Safe for Most aHUS Patients, Study Finds

One-Fifth of Home Health Agencies Halt Telehealth Services After Pandemic

Proteomic Test Cuts Childhood Rare Disease Diagnosis to Under Three Days